Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15234462 | 0.94 | NAAA (0.59) | ALDH1A1NAAAATMDGKATSHR | |
| SCHEMBL9294114 | 0.92 | NAAA (0.62) | ALDH1A1NAAADGKATSHRRAD52 | |
| SCHEMBL15796763 | 0.92 | NAAA (0.62) | ALDH1A1NAAADGKATSHRRAD52 | |
| SCHEMBL23925422 | 0.88 | ALDH1A1 (0.50) | ALDH1A1NAAAATMDGKATSHR | |
| SCHEMBL31058603 | 0.87 | NAAA (0.39) | ALDH1A1NAAADGKATSHRRAD52 | |
| SCHEMBL9001086 | 0.85 | ALDH1A1 (0.52) | ALDH1A1NAAAATMDGKATSHR | |
| SCHEMBL15876200 | 0.85 | ALDH1A1 (0.52) | ALDH1A1NAAAATMDGKATSHR | |
| SCHEMBL522692 | 0.85 | ALDH1A1 (0.52) | ALDH1A1NAAAATMDGKATSHR | |
| SCHEMBL95964 | 0.83 | ALDH1A1 (0.50) | ALDH1A1NAAAATMDGKATSHR | |
| Ammonia Solution, Strong SCHEMBL27789119 | 0.83 | ALDH1A1 (0.50) | ALDH1A1NAAAATMDGKATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042727-A1 | COMPLEX OF 3-HYDROXY-3-METHYLBUTYRIC ACID AND SALT THEREOF, AND PREPARATION METHOD THEREFOR | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2026-02-12 | — | — | US | claimed |
| WO-2024153236-A1 | COMPLEX OF 3-HYDROXY-3-METHYLBUTYRIC ACID AND SALT THEREOF, AND PREPARATION METHOD THEREFOR | 南京纽邦生物科技有限公司 | 2024-07-25 | — | — | WO | claimed |
| US-20260042727-A1 | COMPLEX OF 3-HYDROXY-3-METHYLBUTYRIC ACID AND SALT THEREOF, AND PREPARATION METHOD THEREFOR | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2026-02-12 | — | — | US | disclosed |
| WO-2024153236-A1 | COMPLEX OF 3-HYDROXY-3-METHYLBUTYRIC ACID AND SALT THEREOF, AND PREPARATION METHOD THEREFOR | 南京纽邦生物科技有限公司 | 2024-07-25 | — | — | WO | disclosed |
| US-9885886-B2 | UV blocker loaded contact lenses | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170212365-A1 | UV Blocker Loaded Contact Lenses | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2017-07-27 | — | — | US | disclosed |
| US-9594188-B2 | UV blocker loaded contact lenses | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| CN-104107700-A | Industrial organic exhaust gas combustion catalyst and preparation method thereof | LANZHOU CHEM PHYS INST | 2014-10-22 | — | — | CN | disclosed |
| EP-2788815-A1 | UV BLOCKER LOADED CONTACT LENSES | University of Florida Research Foundation, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| US-20140288206-A1 | UV BLOCKER LOADED CONTACT LENSES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2014-09-25 | — | — | US | disclosed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-5436254-A | Vaopressin antagonists | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0620003-A1 | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5244898-A | Vasopressin antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0514667-A1 | Benzazepin derivatives as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-25 | — | — | EP | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042727-A1 | COMPLEX OF 3-HYDROXY-3-METHYLBUTYRIC ACID AND SALT THEREOF, AND PREPARATION METHOD THEREFOR | HCN3, CPT1B, PYGM | ALDH1A1 4110/4885NAAA 3858/4885ATM 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.